Subject: This Pick is Set to Soar Check out VMGI

SCV Client Spotlight VMGI Logo
Huge News Out Today

Verde Media Group, Inc.
1901 Avenue of the Stars
2nd Floor
Los Angeles, CA 90067
Phone: (310) 954-9160

Facebook Twitter


Verde Media Group Inc. ("Verde Media", "VMGI" or the "Company") is a publicly traded company listed on the OTC Markets traded under the stock symbol VMGI. The Company consists of three integrated divisions:

Verde Agency Division
The Verde Agency Division ("Verde Agency") provides public relations, marketing and corporate finance services to clients in various industries. Verde Agency is currently focusing its resources on supporting the VMGI portfolio of companies.

Verde Entertainment Division
The Verde Entertainment Division ("Verde Entertainment") operates a managed media company with production, distribution, development and acquisition functions for film, television and multi-media. Utilizing all available media platforms the company has the capacity, experience and infrastructure to produce content ranging from corporate advertising and reality television to independent film. In addition, Verde Entertainment manages content libraries, digital imaging solutions and distribution functions for clients' media needs.

BioTech Division
The Biotech Division manages a portfolio of biotech companies currently comprised of the following:

Verde Biotechnology Corp. (“VBC”)
VBC, incorporated in the State of Delaware, is a wholly owned subsidiary of Verde Media. VBC’s focus is on: i) developing and producing high value bio-products from renewable biomass; and ii) scaling the technology to demonstrate commercial scale operations for third party licensing. VBC has recently acquired the majority interest of Butazyme LLC (“Butazyme” or “BTZ”).

Dr. S. Hussain I. Abidi, Ph.D., CEO Verde Biotechnology Corp., BOD
Dr. Abidi received his doctorate degree at the University of Oxford specializing in the area of Molecular Genetics and Biotechnology. He continued his academic career at Harvard Medical School as a post-doctorate research fellow and studied reproductive stem cell biology. Dr. Abidi further research focused on metabolic engineering, the engineering of microbes for the production of high value bio products at the MIT department of Chemical Engineering. His deep domain experience uniquely integrates medical sciences and microbial research background with the development of commercial biotech applications including renewable and sustainable microbial omega-3 oil production platforms. He has produces an impressive body of work published in major journals such as Cell, Cell Research, BMC Genomics and authored a number of high profile patents licensed to start-up companies globally. Dr. Abidi is a member of American Society of Microbiology and elected as a fellow of Sigma Xi - one of the world's most eminent scientific research societies.

Butazyme, LLC.
Headquartered in Boston, Massachusetts, Butazyme, is a biotechnology company focused on producing highly concentrated, natural, microbial omega-3 oils from low cost feedstock such as municipal waste, animal waste and biomass derived sugar streams. The microbial derived Omega-3 oil market is expected to reach 34 billion dollars by 2016 with growth rates of 10-15%. Butazyme is initially focused on integrating its omega-3 oil production within the aquaculture and livestock industries. The company has signed a joint venture agreement for the development of a commercial scale plant in Asia and expects revenues of 16mm dollars for its year ended 2016.

BTZ Strategic Partners

Biothane, a subsidiary of Veolia Water Solutions & Technologies, in the U.S., has constructed 540 bio-methane installations in more than 40 countries worldwide. Biothane develops detailed engineering designs and integrated control systems to control and monitor dissolved oxygen for efficient growth and production of microbial omega-3 oils for the project.
Applied Chemical Technology, Inc.
Applied Chemical Technology, Inc. (ACT) is an engineering firm providing consulting service to the chemical industry employing a team of professional engineers, designers, laboratory and computer technicians, and master craftsmen, as well as business and support staff. ACT specializes in the design and construction of large and small-scale production plants for chemical products and processes.

Beautyject Inc.
Beautyject Inc., (“Beautyject” or “BJI”), incorporated in the State of Nevada, is a majority owned subsidiary of Verde Media. Beautyject is the first company to offer needle-free technology fully adapted to the beauty care and cosmetic markets. The injectors can be used to administer liquid cosmetic products such as Botox, hyaluronic acid, vitamins and a variety of other products to the top layers of the skin through a non-invasive, needle-free, painless delivery system. Previously unavailable for private use, individuals can now administer unique formulations to treat superficial lines, minor skin damage, fine wrinkles, moisture and skin elasticity all at the convenience of their homes with no risk of needle stick injuries and damage to the skin. Practitioners benefit from attracting new clientele, new upsell opportunities for existing treatments such as Botox, precision treatment delivery, increased client satisfaction and increased profitability due to complete emptying of ampoules and a longer shelf life. The company is in advanced discussions with an internationally recognized distribution group that has access to major broadcasting and satellite TV networks for the sale and distribution of its beauty products throughout North America and expects revenues to reach upwards of 25 million dollars in its third year of commercialization.

Strategic partners:
  • Kevin Harrington- Marketing and direct sales partner.
  • All of the Company’s cosmeceutical formulations and carpules are prepared at Panaxia located in Israel. Panaxia is an R&D company as well as a manufacturer of medical devices and cosmeceuticals.
  • All of the Company’s injectors are assembled at Jonas & Redman located in Berlin.
  • The ampoules, the heart of the Company’s products, will be produced at Beyonics located in Singapore, Southeast Asia.
  • The Company’s adapters are assembled using proprietary molds at Raro Plastics GmbH located in Berlin, Germany.

Value Proposition:

  • Verde Media Group Inc. has signed a definitive agreement, through its subsidiary Beautyject Inc., with an internationally-recognized team from Power Shark Capital (PSC) for the marketing, sale and distribution of its cosmetic products throughout the United States and Canada.
  • Power Shark Capital is a coordinated effort of global entrepreneur Jean Jean Pelletier and advertising guru Kevin Harrington, popularly known as star of the network television show, Shark Tank. The group has a storied history of experience in business and advertising, Mr. Harrington having personally sold more than 4 Billion dollars worth of products through television-based promotional campaigns and defining the infomercial industry as it is known today.
  • Beautyject has granted to PSC exclusive distribution, sales and marketing rights of its cosmetic needle-free kits and products for North America. In correlation with Mr. Harrington's proven methods, PSC will be handling all sales and distribution through infomercials, TV commercials and other direct marketing methods at PSC's cost.
VMGI Chart

Pink Sheets: VMGI

Market Value
4,250,000 a/o May 14, 2014

Shares Outstanding
500,000,000 a/o Feb 21, 2014

259,239,337 a/o Feb 21, 2014

Authorized Shares
500,000,000 a/o Jun 30, 2013

Par Value:

Shareholders of Record
229 a/o Mar 31, 2013

Public Float:

Transfer Agent:
Olde Monmouth Stock Transfer Co., Inc.


Verde Media Group Inc. Biotech Division Launches Mobile VMBD-03 Laboratory to Serve the Omega-3 Project in Asia

Verde Media Group Inc. Announces the Completion of Land Acquisition and Site Security as Large-Scale Overseas Omega 3 Project Moves Forward In Phase-I


William F. Veve


Adam DesLauriers

Dr. S. Hussain I. Abidi, Ph.D.

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks